142 related articles for article (PubMed ID: 38559201)
1. Early Initiation of Ceftaroline-Based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia.
Hicks AS; Dolan MA; Shah MD; Elwood SE; Platts-Mills JA; Madden GR; Elliott ZS; Eby JC
Res Sq; 2024 Mar; ():. PubMed ID: 38559201
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant
Huang C; Chen I; Lin L
Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009973
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
4. Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline.
Ahmad O; Crawford TN; Myint T
Infect Dis Ther; 2020 Mar; 9(1):77-87. PubMed ID: 31776844
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
[TBL] [Abstract][Full Text] [Related]
6. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes With Definitive Treatment of Methicillin-Resistant
Nichols CN; Wardlow LC; Coe KE; Sobhanie MME
Open Forum Infect Dis; 2021 Jul; 8(7):ofab327. PubMed ID: 34337094
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia.
Patel D; Brown ML; Edwards S; Oster RA; Stripling J
Int J Antimicrob Agents; 2023 Mar; 61(3):106735. PubMed ID: 36690124
[TBL] [Abstract][Full Text] [Related]
9.
Davis KP; McDermott LA; Snydman DR; Aldridge BB
Microbiol Spectr; 2024 Jun; ():e0097624. PubMed ID: 38916355
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant
Hornak JP; Anjum S; Reynoso D
Ther Adv Infect Dis; 2019; 6():2049936119886504. PubMed ID: 31857898
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia.
Cabanilla MG; Bernauer ML; Briski MJ; Atallah LM; Koury J; Thompson CM; Rodriguez CN; Jakeman B; Byrd TF
J Pharm Technol; 2024 Jun; 40(3):134-141. PubMed ID: 38784026
[No Abstract] [Full Text] [Related]
13. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of Methicillin-Resistant
Patatanian E; Chandler C
Hosp Pharm; 2016 Jan; 51(1):68-70. PubMed ID: 38745720
[TBL] [Abstract][Full Text] [Related]
16. Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study.
Hammond J; Benigno M; Bleibdrey N; Ansari W; Nguyen JL
Drugs Real World Outcomes; 2024 Jun; 11(2):273-283. PubMed ID: 38564101
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant
Zasowski EJ; Trinh TD; Claeys KC; Lagnf AM; Bhatia S; Klinker KP; Veve MP; Estrada SJ; Johns ST; Sawyer AJ; Huang V; LaFrance B; Levine DP; Kaye KS; Davis SL; Rybak MJ
Open Forum Infect Dis; 2022 Mar; 9(3):ofab606. PubMed ID: 35146040
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
